In the absence of CD8+ T cells, propranolol and β2-AR knockout (KO) mice do not exert their anti-tumor effects, which signifies that the β2-AR blockade, apart from affecting tumor intrinsic pathways, improves the status of anti-tumor immunity and, hence, leads to better anti-tumor control [51]. Here, ADRB2 is linked to neoplasm.